S&P 500 7,323.63 −0.23%
Nasdaq 24,429.89 +0.42%
S&P/TSX 34,578.05 −2.09%
Apple 352.45 +0.15%
Nvidia 150.96 −2.89%
Microsoft 508.29 +0.40%
Shopify 199.78 −1.50%
Royal Bank 272.26 −3.11%
CAD/USD 0.6992 −0.02%
PRE-MKT · 05:55 ET
Market ClerkRecap
Thu Nov 19 · pre-market7 signals on Nov 18520 insider buys this week · $248.1MCIRO short report next: Nov 30The week ahead

USNA

USANA HEALTH SCIENCES INC
NYSE · HEALTH CARE · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS
13.22
−0.35 −2.58%
USD · close Nov 18

A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up

MKT CAP $244.3MP/E —DIV YIELD —FCF YIELD 6.52%REV TTM $913.4M +1.6%NET INCOME −$22.2M −165.0%NET CASH —52W 12.73 – 23.24SEC XBRL · TTM TO Invalid Date

Financials

SEC XBRL · 62 PERIODS · WHOLE USD

By quarter

PeriodRevenueYoYGross marginOperating incomeNet incomeYoYEPSOp. cash flowCapexFree cash flowFiled
Q2 2027 · Jul 4$223.3M−5.3%78.3%−$20M−$21.4M−321.5%-1.16$23.3M$3.2M$20.2MAug 13
Q1 2027 · Apr 4$250.2M+0.3%76.2%$13.9M$7.5M−20.1%0.41$9.8M$2.6M$7.1MMay 12
Q4 2026 · Jan 3derived$226.2M+5.9%78.2%$3.8M−$1.8M−139.9%-0.09−$3.4M$2.8M−$6.2MMar 16
Q3 2026 · Sep 27$213.7M+6.7%77.2%$1.2M−$6.5M−161.5%-0.36−$2M$3.2M−$5.2MNov 5
Q2 2026 · Jun 28$235.8M+10.8%78.7%$16.7M$9.7M−7.4%0.52$12.2M$5M$7.2MAug 13
Q1 2026 · Mar 29$249.5M+9.5%79.0%$15.7M$9.4M−43.1%0.49$15.5M$2.8M$12.7MMay 12
Q4 2025 · Dec 28derived$213.6M−3.4%82.0%$8.2M$4.5M−73.4%0.23$5.8M$1.8M$4MMar 16
Q3 2025 · Sep 28$200.2M−6.2%80.4%$15.6M$10.6M−6.5%0.56$29.5M$2.4M$27.1MNov 5
Q2 2025 · Jun 29$212.9M—81.1%$17.8M$10.4M—0.54$8M$2.7M$5.3MAug 5
Q1 2025 · Mar 30$227.8M—81.1%$24.7M$16.5M—0.86$17.7M$3.2M$14.5MMay 6
Q4 2024 · Dec 30derived$221.1M—80.9%$24.2M$16.8M—0.87$26M$7.3M$18.7MMar 16
Q3 2024 · Sep 30$213.4M—80.1%$17.6M$11.3M—0.59$22.2M$1.5M$20.8MNov 5

By fiscal year

YearRevenueGross marginOperating incomeNet incomeNet marginEPSOp. cash flowCapexFree cash flowBuybacksDividends paid
FY2026 · to Jan 3$925.3M78.3%$37.4M$10.8M1.2%0.58$22.3M$13.8M$8.5M$27.5M—
FY2025 · to Dec 28$854.5M81.1%$66.3M$42M4.9%2.19$61M$10.1M$50.9M$9.4M—
FY2024 · to Dec 30$921M80.8%$93.1M$63.8M6.9%3.30$70.6M$14.5M$56.1M$11.6M—
FY2023 · to Dec 31$998.6M80.6%$107.6M$69.3M6.9%3.59$103.9M$10.4M$93.5M$25.4M—
FY2022 · to Jan 1$1.2B81.6%$170.2M$116.5M9.8%5.73$121.2M$12.8M$108.5M$177.8M—
FY2021 · to Jan 2$1.1B81.6%$176.5M$124.7M11.0%5.86$160.4M$15.1M$145.3M$57M—

Every number comes from USANA HEALTH SCIENCES INC's own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.

Watch USNA. Know when insiders buy.
One email the day a filing lands. Free.